Company Filing History:
Years Active: 2020
Title: Takahiro Yamamoto: Innovator in Albumin-Sugar Chain Complex Technology
Introduction
Takahiro Yamamoto is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biochemistry, particularly with his innovative work on albumin-sugar chain complexes. His research aims to enhance the stability and functionality of these complexes within the body.
Latest Patents
Takahiro Yamamoto holds a patent for an albumin-sugar chain complex. The objective of this invention is to provide a complex that is bound with a sufficient number of sugar chains to achieve a clustering effect while maintaining stability in the body. The patent describes an albumin-sugar chain complex that has five or more molecules of an asparagine-linked sugar chain bound per molecule of albumin. This complex serves as a carrier for selectively delivering functional molecules to target tissues in the body. Additionally, it can be utilized as a bioimaging probe, with the albumin-sugar chain complex as its active ingredient.
Career Highlights
Throughout his career, Takahiro Yamamoto has worked with prominent companies in the biotechnology sector. He has been associated with Glytech, Inc. and Riken Corporation, where he has contributed to various research and development projects. His work has been instrumental in advancing the understanding and application of sugar chain complexes in medical science.
Collaborations
Takahiro Yamamoto has collaborated with esteemed colleagues, including Katsunori Tanaka and Yasuyoshi Watanabe. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Takahiro Yamamoto's contributions to the field of biochemistry, particularly through his patent on albumin-sugar chain complexes, highlight his role as an innovator. His work not only enhances the understanding of sugar chain interactions but also paves the way for future applications in medicine.